Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06548074 · ClinicalTrials.gov registry record · NA

H-PACE Program for the Improvement of Lifestyle Behaviors Among Children

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
122
Enrollment target

NCT06548074: Completed NA study, sponsored by Fred Hutchinson Cancer Center.

NCT06548074 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06548074, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

This clinical trial tests the effectiveness of a Healthy Parents and Children Enhancement (H-PACE) program for improving lifestyle behaviors among children. Proper nutrition and physical activity (PA) are essential parts of overall health. Together, they can decrease the risk of developing obesity as well as related diseases such as diabetes, heart disease, stroke, and several types of cancer. To address the prevalence of obesity and related diseases, programs focusing on increasing opportunities for active living and healthy eating are necessary. Multi-component school-based obesity prevention programs have demonstrated increases in PA and improvement in dietary habits; however, most afterschool programs are short term; evidence is needed to confirm long-term effects. Moreover, programs that involve parents have shown to be more successful in helping children choose healthier behaviors. Unfortunately, due to technological advancement, opportunities for children to be active in schools have become more limited in modern society. H-PACE program is based on the national childhood obesity prevention campaign designed to help families, schools, communities, and physicians to raise awareness of nutritional and PA daily guidelines. The H-PACE will encourage daily lifestyle behaviors (five or more servings of fruits and vegetables, two hours or less of recreational screen time, one hour of PA, zero sugary drinks, ten hours of sleep) that impact childhood obesity. This trial is being done to determine whether participating in the H-PACE program may help improve lifestyle behaviors among children.

Primary Outcome

Will be assessed using descriptive statistics. Will be considered a success from a feasibility standpoint if \> 75% of participants meet the metric.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Supportive Care
  • OTHER Accelerometer
  • BEHAVIORAL H-PACE Behavioral Intervention

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2024-01-22
Est. Completion 2025-05-30
Phase NA
Fred Hutchinson Cancer Center

483 total trials

What the finished NCT06548074 record still lists

NCT06548074 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT06548074 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06548074 about?

NCT06548074 is a clinical study titled "H-PACE Program for the Improvement of Lifestyle Behaviors Among Children". This clinical trial tests the effectiveness of a Healthy Parents and Children Enhancement (H-PACE) program for improving lifestyle behaviors among children. Proper nutrition and physical activity (PA) are essential parts of overall health. Together, they can decrease the risk of developing obesity a...

What is the current status of trial NCT06548074?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2024-01-22. Estimated completion is 2025-05-30.

What interventions are being tested in trial NCT06548074?

The interventions under investigation include: Questionnaire Administration (OTHER), Supportive Care (OTHER), Accelerometer (OTHER), H-PACE Behavioral Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06548074?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06548074's enrollment target sits among peer trials

122 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06548074, the US trial registry maintained by the National Library of Medicine. NCT06548074 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.